Sermorelin, GHRP-6, GHRP-2 9mg (Blend)

Sermorelin, GHRP-6, GHRP-2 9mg (Blend) — Advanced Triple-Action Pituitary Secretagogue Research Formulation

This advanced 9mg synergistic formulation combines three of the most prominent growth hormone-releasing agents in peptide science: Sermorelin, GHRP-6, and GHRP-2. By pairing a classic Growth Hormone-Releasing Hormone (GHRH) analogue with two distinct Growth Hormone Secretagogue Receptor (GHSR) agonists, this triple-blend offers a comprehensive architecture to investigate multi-pathway endogenous growth hormone amplification.

• Triple-Pathway Synergy: Simultaneously targets distinct pituitary receptor pathways. Sermorelin stimulates the GHRH receptors, while GHRP-6 and GHRP-2 offer complementary binding kinetics at the ghrelin/secretagogue receptors to suppress somatostatin, evaluating an amplified and highly efficient cellular signaling cascade.

• Key Research Areas: Extensively utilized in metabolic, endocrinological, and cellular aging studies to investigate lean tissue preservation, adipose tissue metabolism, cellular repair mechanisms, and physiological feedback loops.

• Purity Guaranteed: $\ge 99\%$ purity of each constituent peptide within the blend, verified by rigorous HPLC and Mass Spectrometry testing to maintain exact and repeatable experimental baselines.

• Optimal Stability: Supplied as a sterile, lyophilized powder format to protect delicate peptide chains, ensuring excellent structural integrity and straightforward reconstitution for in vitro and laboratory assays.

Note: This product is sold strictly as a high-purity research chemical. It is intended solely for laboratory, in vitro, or animal research applications and is not approved for human injection, therapeutic, or diagnostic use.